The management of immune thrombocytopenia (ITP) and the prediction of patient response
to therapy still represent a significant and constant challenge in hematology. ITP is a …

Summary Interleukin-22 (IL-22) is a vital cytokine that is dysregulated in various autoimmune
conditions including rheumatoid arthritis (RA), multiple sclerosis (MS), and Alzheimer's …

免疫性血小板减少症(immunethrombocytopenia, ITP) 是一种常见的自身免疫性出血性疾病,
表现为外周血血小板计数减低. 针对ITP 的经典初始治疗方案仍为糖皮质激素 …

Background Sovleplenib, a novel spleen tyrosine kinase (SYK) inhibitor, showed promising
safety and activity in patients with primary immune thrombocytopenia in a phase 1b/2 trial …

Health risk prediction aims to forecast the potential health risks that patients may face using
their historical Electronic Health Records (EHR). Although several effective models have …

Background Some observational studies have shown that immune thrombocytopenia (ITP)
is highly associated with the alteration-composition of gut microbiota. However, the causality …

This study aimed to identify key proteomic analytes correlated with response to splenectomy
in primary immune thrombocytopenia (ITP). Thirty‐four patients were retrospectively …

Immune thrombocytopenia (ITP), an acquired autoimmune disease, is characterized by
immune-mediated platelet destruction. A biomarker is a biological entity that contributes to …

Autoimmune disorders place a substantial burden on the healthcare system all over the
world affecting almost 3% to 8% of the population. Immune thrombocytopenic purpura (ITP) …

Immune thrombocytopenia (ITP) is an autoimmune disorder that causes a significant
reduction in peripheral blood platelet count. Fortunately, due to an increased understanding …